Tirzepatide Cost in the UK: What Honest Pricing Looks Like

What UK private tirzepatide pricing actually reflects

There is a common assumption that tirzepatide costs are just the pen plus a margin. The reality is more layered. After Eli Lilly raised its UK list price from 1 September 2025, the cost of the highest-dose pen rose from around £122 to around £330 at list, a change that rippled through every private provider almost immediately. Reported private prices since then range roughly £149 to £375 a month depending on dose and provider (as widely reported and confirmed by Lilly UK's published announcement). Lower doses sit at the lower end of that range, and if you are starting treatment it is worth reading about what the introductory 2.5mg dose typically costs before committing to a provider; the 15mg pen, used as a maintenance dose by many patients, sits nearer the top.

The tirzepatide UK cost you see advertised is usually the cost of one pen covering four weekly doses. What varies enormously between providers is what else sits behind that number. A legitimate service requires a qualified prescriber to assess you, a GPhC-registered pharmacy to dispense and check the medicine, and a clinical process at every repeat. Those things cost something, and they should.

If you want more detail on dose-specific figures, the cost of the 5mg tirzepatide pen or the 15mg pen pricing are covered separately.

What headline prices often leave out, and why that matters

A price that looks sharp is sometimes a price with pieces missing. The costs most commonly stripped from headline figures include the initial consultation fee, the prescription charge, delivery, and any form of aftercare or clinical oversight between orders. Some providers charge these separately; others fold them in selectively. A £149 headline becomes considerably more expensive once those elements are added back.

There is also the question of ongoing clinical review. NICE's guidance on tirzepatide (TA1026) is clear that treatment requires assessment at six months to confirm meaningful weight response, a process that should involve a real prescriber, not an automated renewal. Check how our consultation process works if you want to see what genuine clinical oversight looks like in practice.

Prescribing of tirzepatide is also subject to NHS England's wrap-around care requirements. If your provider cannot describe what happens between your orders, that is worth pausing over. Our FAQs page covers what to expect at each stage.

Where nume sits on price, and why we don't compete on it

Cheapest is not a race we entered. One transparent price at nume covers the consultation, the prescription, the medicine, next-working-day DPD delivery and 7-day-a-week aftercare. Nothing is added at checkout. We run no discount codes, no vouchers and no promotional offers. The current treatment pricing is shown on our weight-loss treatments page; we don't print per-pen figures in body copy because prices can move and we prefer to be accurate rather than optimistic.

Every consultation at nume is personally read by a GPhC-registered Independent Prescriber on the same day. Our clinical team page puts a name to that oversight. Before your first order, we verify your identity with photo ID and confirm your weight on a short video call. Every repeat order gets the same clinical re-review before it is approved. That is not standard across every provider, and it is part of what the price reflects.

We are transparent about what we are: a GPhC-registered online pharmacy (registration number 9012878, verifiable at the GPhC pharmacy register) dispensing through the licensed UK supply chain. No shortcuts, no grey-market stock.

Why 'cheapest' is the wrong question to ask about a prescription medicine

For a prescription-only medicine, low price is not a safety signal. The MHRA has warned repeatedly about fake tirzepatide and semaglutide pens circulating online, including through social media. In October 2025 the MHRA raided a site in Northampton manufacturing counterfeit tirzepatide pens. Roughly 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million were seized during 2025 enforcement actions, and patients researching tirzepatide costs in other markets such as New Zealand should be especially cautious about cross-border sellers whose supply chains are impossible to verify. Fake pens have been found to contain insulin rather than the labelled medicine.

Red flags for unregulated supply include sellers offering these medicines without a prescription, prices significantly below the market range, and discount codes from unverified sources. You can verify any online pharmacy on the GPhC pharmacy register. If you suspect a seller, the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk accepts reports.

The right question is not which provider charges least but whether the clinical process is sound, the supply chain is licensed, and the prescriber is qualified and accountable. Those are the factors that determine whether the medicine you receive is genuine and appropriate for you, and they matter just as much when you reach higher doses, where you can find a breakdown of what the 10mg tirzepatide pen costs and what that price should include. If you are ready to start that process properly, speak to our prescribers through a free consultation today.